Skip to content

Public FDA record

Z-0026-2025: BD Synapsys Informatics Solution with software versions: 4.20, 4.30, 5.10, 5.20 and 5.30- IVD standalone

Recall record Z-0026-2025 for Becton Dickinson & Co.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0026-2025
Company in FDA record
Becton Dickinson & Co.
FDA classification date
Oct 8, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Synapsys software versions 4.20, 4.30, 5.10, 5.20, or 5.30 and utilizing the in-line breakpoint feature, an error is occurring where BD Synapsys will incorrectly display breakpoints for organisms that do not have defined breakpoints in CLSI or EUCAST. This occurs when the identified organism is included in the same interpretive group as a species for which there is a specific breakpoint. May result in either a false susceptible or false resistant result. A false susceptible result can cause inadequate or incomplete antibiotic treatment due to the use of an ineffective antibiotic, and a false resistant result may limit access to a preferred antibiotic regimen with possible elongation of therapy

Source facts

Action
BD issued Urgent Medical Device Correction letter on 12Sep2024. Letter states reason for recall, health risk and action to take: 1.Immediately identify if you have the affected software version noted in the affected product tableabove. Reference Attachment 2 for software version verification instructions. 2.Determine if the feature is active in your system by reviewing the system settings. Refer toAttachment 3 for System settings breakpoint feature instructions. 3.If the inline breakpoint feature is enabled, please disable the feature and keep disabled untilupgraded to Synapsys" software versions 5.31 or later. Refer to Attachment 3 for Systemsettings breakpoint feature instructions. 4.Ensure the contents of this notification are read and understood. 5.Share and post this customer letter within your facility network and forward to any customers to whom you may have distributed the product to ensure awareness. 6.Complete the attached Customer Response Form and return to the BD contact noted on the form whether or not you have any of the affected software versions, so that BD may acknowledge your receipt of this notification per FDA requirements. Actions taken by BD 1.BD has identified the root cause and is taking action to prevent recurrence of this product issue. 2.BD has resolved the issue in software versions 5.31 and later. If you require further assistance, please contact: BD Contact US Contact Information Areas of Support North American Regional Complaint Center Phone: 1-844-8BD-LIFE (1-844-823-5433) Say Complaints when prompted Mon Fri 8:00am and 5:00pm CT or Email: productcomplaints@bd.com
Initiated
2024-09-12
Root cause
Under Investigation by firm
Distribution
Nationwide Foreign: Australia, New Zealand, Singapore, Hong Kong, Taiwan, Japan, Austria, Belgium, Denmark, France, Germany, Italy, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom, Russia, Saudi Arabia, South Africa, Canada, Mexico, China
Recall number
Z-0026-2025
Recall status
Open, Classified
CDRH record ID
210127
FDA classified
2024-10-08
Recall event number
95394

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗